Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Psoriasis severity | |||||
RCT 3-armed trial |
38 people with mild to moderate chronic stable plaque psoriasis |
Median modified Psoriasis Area and Severity Index (PASI) score
3.9 with UVA 4.2 with placebo (visible light) |
P = 0.04 |
Effect size not calculated | UVA |